Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 16, Issue 4, Pages 568
Publisher
MDPI AG
Online
2023-04-10
DOI
10.3390/ph16040568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment-Resistant Depression in Poland—Epidemiology and Treatment
- (2022) Piotr Gałecki et al. Journal of Clinical Medicine
- Ketamine; history and role in anesthetic pharmacology
- (2022) Kazuyoshi Hirota et al. NEUROPHARMACOLOGY
- The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression
- (2022) Muhammad Youshay Jawad et al. NEUROPHARMACOLOGY
- Ketamine and its metabolites: Potential as novel treatments for depression
- (2022) Kai Zhang et al. NEUROPHARMACOLOGY
- Treatment-Resistant Depression Revisited: A Glimmer of Hope
- (2021) Angelos Halaris et al. Journal of Personalized Medicine
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Perspectives for therapy of treatment‐resistant depression
- (2021) Mariusz Papp et al. BRITISH JOURNAL OF PHARMACOLOGY
- Do sleep changes mediate the anti‐depressive and anti‐suicidal response of intravenous ketamine in treatment‐resistant depression?
- (2021) Nelson B. Rodrigues et al. JOURNAL OF SLEEP RESEARCH
- BDNF signaling in context: From synaptic regulation to psychiatric disorders
- (2021) Camille S. Wang et al. CELL
- Off‐Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk‐Benefit Profile
- (2021) Sudhakar M. Pai et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review
- (2021) Bijia Song et al. Frontiers in Pharmacology
- Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
- (2021) Alina Wilkowska et al. Frontiers in Psychiatry
- A New Paradigm for Achieving a Rapid Antidepressant Response
- (2020) Gin S. Malhi et al. DRUGS
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments
- (2020) Luke A. McGuinness et al. Research Synthesis Methods
- The clinical characterization of the adult patient with depression aimed at personalization of management
- (2020) Mario Maj et al. World Psychiatry
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
- (2019) Katrina Witt et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Defining treatment‐resistant depression
- (2019) Bradley N. Gaynes et al. DEPRESSION AND ANXIETY
- International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
- (2018) F. Caraci et al. PHARMACOLOGICAL REVIEWS
- Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
- (2018) A. Kautzky et al. ACTA PSYCHIATRICA SCANDINAVICA
- Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission
- (2018) Helen Herrman et al. LANCET
- Definition of treatment-resistant depression – Asia Pacific perspectives
- (2018) C.H. Ng et al. JOURNAL OF AFFECTIVE DISORDERS
- Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder
- (2017) Jennifer L. Vande Voort et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Antidepressants on Sleep
- (2017) Adam Wichniak et al. Current Psychiatry Reports
- Ketamine abuse potential and use disorder
- (2016) Yu Liu et al. BRAIN RESEARCH BULLETIN
- Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder
- (2016) Elizabeth D. Ballard et al. JOURNAL OF CLINICAL PSYCHIATRY
- Intensive Sleep Deprivation and Cognitive Behavioral Therapy for Pharmacotherapy Refractory Insomnia in a Hospitalized Patient
- (2014) Joshua Breitstein et al. Journal of Clinical Sleep Medicine
- Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
- (2014) Elizabeth D. Ballard et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
- (2014) B G Bunney et al. MOLECULAR PSYCHIATRY
- Association of Poor Subjective Sleep Quality With Risk for Death by Suicide During a 10-Year Period
- (2014) Rebecca A. Bernert et al. JAMA Psychiatry
- Rapid Treatment Response of Suicidal Symptoms to Lithium, Sleep Deprivation, and Light Therapy (Chronotherapeutics) in Drug-Resistant Bipolar Depression
- (2013) Francesco Benedetti et al. JOURNAL OF CLINICAL PSYCHIATRY
- The DSM-5: Classification and criteria changes
- (2013) Darrel A. Regier et al. World Psychiatry
- Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010
- (2013) Alize J. Ferrari et al. PLOS MEDICINE
- Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
- (2012) Wallace C. Duncan et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Residual Symptoms in Depressed Outpatients Who Respond by 50% But Do Not Remit to Antidepressant Medication
- (2011) Shawn M. McClintock et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report
- (2009) A. A. Nierenberg et al. PSYCHOLOGICAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now